When recommending an insulin pen to a patient, do you have sample pens to demonstrate how to use properly? Follow the link to see how you compare to your colleagues.

Your 42-year-old, overweight patient was diagnosed with type 2 diabetes (A1C 7.7%) five months ago. You discussed the diagnosis with him, prescribed metformin, and provided lifestyle modification education resources. He missed his follow-up appointment, so you called him to schedule a return visit. At this appointment, he shares some of the positive lifestyle modifications he has made and that he has been taking his metformin consistently. He currently takes 2,000 mg metformin per day. At this visit, his A1C is 9.4%. All of the following are reasonable treatment options EXCEPT: A. Metformin+ lifestyle modifications B. Metformin + once-daily evening basal insulin dose + lifestyle modifications C. Metformin + sulfonylurea+ lifestyle modifications D. Metformin + GLP-1 receptor agonist + lifestyle modifications Follow the link to see the correct answer.

R. Keith Campbell, RPh, MBA, CDE, FASHP, FAPhA, FAADE, is the former Associate Dean and is the Distinguished Professor in Diabetes Care/Pharmacotherapy at the Washington State University College of Pharmacy in Pullman, Washington.

R. Keith Campbell discusses his work as a pharmacist and a professor at the Washington State University and his personal experience with diabetes.

In this Exclusive Interview, Keith Campbell talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about his years of experience not only as a pharmacist and diabetes educator, but as a patient with diabetes who has seen great development in a short time with more promising changes to come.

In part 1 of this Exclusive Interview, Keith Campbell talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about his career and the many people impacted by his diabetes education.

In part 2 of this Exclusive Interview, Keith Campbell talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the diabetes care advancements he has seen over the years and the changes he finds exciting.

In part 3 of this Exclusive Interview, Keith Campbell shares his thoughts about upcoming developments in diabetes care with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 4 of this Exclusive Interview, Keith Campbell explains determining the proper combination of medications in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 5 of this Exclusive Interview, Keith Campbell talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the main takeaway from his presentation - an emphasis on patient care.